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Recently Pascual and colleagues have 
contributed a study about the identity of cells 
that initiate metastasis (Pascual et al., 2017). 
They identified a cell type in human oral 
carcinomas with the following properties: (1) 
slow-cycling, (2) CD44-bright, (3) low ex-
pression of mesenchymal genes, (4) ability 
to initiate metastasis in mouse models and 
(5) high expression of the fatty acid receptor 
CD36. CD36 is a membrane protein on the 
surface of many mammalian cells that im-
ports fatty acids (Yang et al., 2018; Um-
barawan et al., 2018; Son et al., 2018). CD36 
has been shown to be critical for supply with 
fatty acids and for maintenance of energy 
metabolism under numerous conditions 
(Wen et al, 2017; Chen et al, 2016; Nakatani 
et al., 2015; le Foll et al., 2015, 2013). In 
their recent study Pascual et al. report that 
neutralizing antibodies against CD36 reduce 
the formation of metastasis in orthotopic 
mouse models of oral cancer (Pascual et al., 
2017). A further finding of this study is that 
NOD scid gamma mice developed larger 
lymph node metastases in a CD36 dependent 
manner, when the mice received a high-fat 
diet. Moreover, the authors report that CD36 
positive cells are metastasis initiating and are 
characterized by a lipid metabolism signature 
(Pascual et al., 2017). Based on publicly 
available data, high expression of CD36 was 
associated with poor disease-free survival in 
breast, lung and urinary bladder cancer (Pas-
cual et al., 2017). 
In the past decade much progress has 
been made in understanding the principles 
that control formation of metastases 
(McGranahan et al, 2017; Lambert et al., 
2017; Adawy, 2017; Marchan, 2012; Ca-
denas, 2012; Mantovani et al., 2017; Zhan et 
al, 2017). It is generally accepted that the 
cellular and humoral immune system play an 
important role in preventing metastasis 
(Schmidt et al., 2018, 2012, 2008; Godoy et 
al., 2014; Heimes et a., 2017a, b; Sicking et 
al., 2014).  
In many tumor types high expression of 
proliferation associated genes has been 
shown to lead to an increased risk of metas-
tasis (Schmidt et al., 2008; Siggelkow et al., 
2012; Jabs et al., 2017; Wei et al,, 2017; 
Knaack, et al, 2018). Moreover, high expres-
sion of antioxidative factors (Cadenas et al, 
2010), disturbed expression of genes in-
volved in the control of circadian rhythm 
(Cadenas et al., 2014) and actin binding pro-
teins (Stock et al., 2015) are associated with 
shorter metastasis-free interval.Different 
principles have been shown to control breast 
cancer metastasis that occurs within the first 
three years after the primary tumor or later 
(Hellwig et al., 2016; Hammad et al., 2016). 
Finally, factors involved in glycerophospho-
lipid metabolism have been shown to influ-
ence the capacity of tumor cells to migrate, 
attach to surfaces and to metastasize (Stewart 
et al., 2012; Lesjak et al., 2014; Marchan et 
al., 2017). 
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In conclusion, Pascual and colleagues 
bring forward an interesting concept that me-
tastasis-initiating tumor cells rely on dietary 
lipids in a CD36 dependent manner. It re-
mains to be shown, whether CD36 is a prom-
ising target for anti-cancer therapy.  
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